Alnylam Patient Education Liaisons (PELs) are professionals with backgrounds in nursing who can provide education to you and your family about hATTR amyloidosis and treatment with ONPATTRO^®, a prescription medicine that treats the polyneuropathy caused by hATTR amyloidosis in adults.

The purpose of the Alnylam PEL team is to provide education to patients, their families, and caregivers.

PELs engage with patients one-on-one to provide education, participate in family meetings, and help raise awareness about hATTR amyloidosis in community health organizations
PELs are employees of Alnylam Pharmaceuticals. They are not acting as healthcare providers and are not part of your healthcare team
PELs do not provide medical care or advice
All diagnosis and treatment decisions should be made by you and your doctor

Request an Alnylam PEL by completing and submitting our form

Request to connect with an Alnylam Patient Education Liaison

Request an Alynlam PEL to contact you by filling out this form.* Required fields

I am a:*

First name*

Last name*

ZIP / postal code*

Email address*

Phone*

OK to leave voicemail. (Optional)

I would like to receive educational resources by mail from Alnylam Pharmaceuticals.

Street address

City

State

I would like to receive updates from Alnylam Pharmaceuticals regarding marketing communications, customer surveys, or for market research surveys.
Alnylam will not sell, share, or transfer my personal data to any unrelated third party for its marketing purposes without my express permission.

By submitting this form, I agree to the . I am 18 years or older, a US resident, and consent to the processing of my personal data per the terms outlined in the and Consent. I understand that Alnylam will use reasonable technical and organizational measures to protect the information I share with the PEL and will not use or disclose it outside of the company.*

Important Safety Information and Indication

Important Safety Information

What are the most important things I should know about ONPATTRO^® (patisiran)?

ONPATTRO can cause:

Infusion-related reactions
ONPATTRO is given as a drip into a vein (called an "intravenous infusion"). Reactions to this infusion may happen during treatment with ONPATTRO. Before each infusion you will be given medicines that help to lower the chance of infusion-related reactions.

Tell your doctor or nurse right away if you experience any of the following signs of an infusion-related reaction during treatment:
- Reddening of the face or body (flushing), skin warm
- Body aches or pain, including pain in the back, neck, or joints
- Feeling sick (nausea)
- Stomach pain
- Feeling short of breath, cough, or other breathing problems
- Headache
- Chest discomfort or chest pain
- Rash
- Chills
- Dizziness
- Feeling tired (fatigue)
- Rapid heart rate
- Facial swelling
If you have an infusion-related reaction, your doctor or nurse may slow down or stop your infusion, and you may need to take other medicines. When these reactions stop, or get better, your doctor or nurse may decide to start the infusion again.
Low Vitamin A levels
Treatment with ONPATTRO lowers the amount of vitamin A in your blood. Your doctor will tell you to take a vitamin A supplement every day. You should not take more than the amount of vitamin A recommended by your doctor.

Low vitamin A levels can affect vision. If you have problems with your vision (e.g., night blindness) while taking ONPATTRO, talk to your doctor. Your doctor may refer you to an eye specialist.

What are the common side effects of ONPATTRO?

The most common side effects of ONPATTRO are respiratory infections, such as colds, sinus infections, and nasal congestion, and infusion-related reactions. These are not all the possible side effects of ONPATTRO. Talk to your doctor about side effects that you experience. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Indication

What is ONPATTRO?

ONPATTRO is a prescription medicine that treats the polyneuropathy caused by an illness called hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis). ONPATTRO is used in adults only.

For additional information about ONPATTRO, please see the full Prescribing Information.

Important Safety Information and Indication

Important Safety Information

What are the most important things I should know about ONPATTRO^® (patisiran)?

ONPATTRO can cause:

Infusion-related reactions
ONPATTRO is given as a drip into a vein (called an "intravenous infusion"). Reactions to this infusion may happen during treatment with ONPATTRO. Before each infusion you will be given medicines that help to lower the chance of infusion-related reactions.

Tell your doctor or nurse right away if you experience any of the following signs of an infusion-related reaction during treatment:
- Reddening of the face or body (flushing), skin warm
- Body aches or pain, including pain in the back, neck, or joints
- Feeling sick (nausea)
- Stomach pain
- Feeling short of breath, cough, or other breathing problems
- Headache
- Chest discomfort or chest pain
- Rash
- Chills
- Dizziness
- Feeling tired (fatigue)
- Rapid heart rate
- Facial swelling
If you have an infusion-related reaction, your doctor or nurse may slow down or stop your infusion, and you may need to take other medicines. When these reactions stop, or get better, your doctor or nurse may decide to start the infusion again.
Low Vitamin A levels
Treatment with ONPATTRO lowers the amount of vitamin A in your blood. Your doctor will tell you to take a vitamin A supplement every day. You should not take more than the amount of vitamin A recommended by your doctor.

Low vitamin A levels can affect vision. If you have problems with your vision (e.g., night blindness) while taking ONPATTRO, talk to your doctor. Your doctor may refer you to an eye specialist.

What are the common side effects of ONPATTRO?

Indication

What is ONPATTRO?

ONPATTRO is a prescription medicine that treats the polyneuropathy caused by an illness called hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis). ONPATTRO is used in adults only.

For additional information about ONPATTRO, please see the full Prescribing Information.

Connect with an Alnylam educator

Request to connect with an Alnylam Patient Education Liaison

Important Safety Information and Indication

Important Safety Information

What are the most important things I should know about ONPATTRO® (patisiran)?

What are the common side effects of ONPATTRO?

Indication

What is ONPATTRO?

Important Safety Information and Indication

Important Safety Information

What are the most important things I should know about ONPATTRO® (patisiran)?

What are the common side effects of ONPATTRO?

Indication

What is ONPATTRO?

What are the most important things I should know about ONPATTRO^® (patisiran)?

What are the most important things I should know about ONPATTRO^® (patisiran)?